drugset / Trial / NCT02209597
Clinical Study of Generic and Brand Bupropion in Depression
RandomizedSequentialDouble-blindTreatment
Summary
Determine bioequivalence between branded and generic bupropion extended release (XL) products (and between generic products) at steady state in patients with major depressive disorder.
Timeline
- Start
- 2014-06-25
- Primary completion
- 2016-08-14
- Completion
- 2016-08-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | 300 mg | — |